The role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 5, 2010, Pages 643-647

  Ince, Deniz Anuk ^a   Atac, Fatma Belgin ^a   Ozkiraz, Servet ^a   Dilmen, Ugur ^b   Gulcan, Hande ^a   Tarcan, Aylin ^a   Ozbek, Namik ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREMATURITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BRONCHOPULMONARY DYSPLASIA; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 78650086333     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0072     Document Type: Article

References (41)

1. Adcock K, Hedberg C, Loggins J, et al. (2003) The TNF-alpha-308, MCP-1-2518 and TGF-beta1\+915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 4:420-426.
2. Akcay A, Ozdemir FN, Ataç FB, et al. (2004) Angiotensin-con- verting enzyme genotype is a predictive factor in the peak panel-reactive antibody response Transplant Proc 36:35-37.
3. Akinnusi ME, El Solh AA (2007) The role of coagulation in pulmonary pathology. Inflamm Allergy Drug Targets 6:201-209.
4. Atac FB, Ince DA, Verdi H, et al. (2010) Lack of association between FXIII-Val34Leu, FVII-323 del/ins, and transforming growth factor beta1 (915G/T) gene polymorphisms and bronchopulmonary dysplasia (a single-center study). DNA Cell Biol 29:13-18.
5. Bancalari E, Claure N (2006) Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 30:164-170.
6. Bancalari E, Claure N, Sosenko IR (2003) Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 8:63-71.
7. Bhandari V, Bizzarro MJ, Shetty A, et al. (2006) Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117:1901-1906.
8. Bokodi G, Treszl A, Kovács L, et al. (2007) B. Dysplasia: a review. Pediatr Pulmonol 42:952-961.
9. Cederqvist K, Sirén V, Petäjä J, et al. (2006) High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome. Pediatrics 117:1226-1234.
10. Celiker G, Can U, Verdi H, et al. (2009) Prevalence of thrombo-philic mutations and ACE I/D polymorphism in Turkish is-chemic stroke patients. Clin Appl Thromb Hemost 15:415-420.
11. Concolino P, Capoluongo E, Santonocito C, et al. (2007) Genetic analysis of the dystroglycan gene in bronchopulmonary dyspla-sia affected premature newborns. Clin Chim Acta 378:164-167.
12. Dawson SJ, Wiman B, Hamsten A, et al. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268: 10739-10745.
13. Eriksson P, Kallin B, van't Hooft FM, et al. (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-1855.
14. Gitto E, Reiter RJ, Sabatino G, et al. (2005) Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res 39:287-293.
15. Härtel C, König I, Köster S, et al. (2006) Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants. Pediatrics 118:683-689.
16. Husain AN, Siddiqui NH, Stocker JT (1998) Pathology of arrested acinar development in postsurfactant broncho-pulmonary dysplasia. Hum Pathol 29:710-717.
17. Idell S, Kueppers F, Lippmann M, et al. (1987) Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 91:52-56.
18. Izuhara Y, Takahashi S, Nangaku M, et al. (2008) Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler Thromb Vasc Biol 28:672-677.
19. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729.
20. Katoh M, Egashira K, Mitsui T, et al. (2000) Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32:73-83.
21. Knaapi J, Lukkarinen H, Kiviranta R, et al. (2006) Cathepsin K expression is diminished in infants with bronchopulmonary dysplasia. Acta Paediatr 95:1298-1300.
22. Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792-1801.
23. Kuba K, Imai Y, Penninger JM (2006) Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol 6:271-276.
24. Liu RM (2008) Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal 10:303-319.
25. Marshall RP, Webb S, Bellingan GJ, et al. (2002) Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 166:646-650.
26. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 11:1215.
27. Morrison CD, Papp AC, Hejmanowski AQ, et al. (2001) Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol 32:521-528.
28. Oikawa T, Freeman M, Lo W, et al. (1997) Modulation of plas-minogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164-172.
29. Ozbek OY, Ataç FB, Ogus E, Ozbek N (2009) Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis. Allergy Asthma Proc 30:41-46.
30. Pavlovic J, Papagaroufalis C, Xanthou M, et al. (2006) Genetic variants of surfactant proteins A, B, C, and D in broncho-pulmonary dysplasia. Dis Markers 22:277-291.
31. Pihusch M, Pihusch V, Holler E (2005) Plasminogen activator inhibitor-1: a review. J Lab Med 29:403-411.
32. Rigat B, Hubert C, Alhenc-Gelas F, et al. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346.
33. Short EJ, Kirchner HL, Asaad GR, et al. (2007) Developmental sequelae in preterm infants having a diagnosis of broncho-pulmonary dysplasia: analysis using a severity-based classification system. Arch Pediatr Adolesc Med 161:1082-1087.
34. Singhal KK, Parton LA (1996) Plasminogen activator activity in preterm infants with respiratory distress syndrome: relationship to the development of bronchopulmonary dysplasia. Pediatr Res 39:229-235.
35. Strandberg L, Lawrence D, Ny T (1988) The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family. Eur J Biochem 176:609-616.
36. Tiret L, Rigat B, Visvikis S, et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angio-tensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205.
37. Vaughan DE, Lazos SA, Tong K (1995) Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 95:995-1001.
38. Walsh MC, Szefler S, Davis J, et al. (2006) Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 117:S52-S56.
39. Yagmurdur MC, Atac FB, Tutar NU, et al. (2008) Prognostic value of the PAI-1 4G/5G polymorphism in invasive ductal carcinoma of the breast. Int Surg 93:163-168.
40. Yanamandra K, Boggs P, Loggins J, Baier RJ (2005) Interleukin-10-1082 G/A polymorphism and risk of death or broncho-pulmonary dysplasia in ventilated very low birth weight infants. Pediatr Pulmonol 39:426-432.
41. Yanamandra K, Loggins J, Baier RJ (2004) The angiotensin converting enzyme insertion/deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. BMC Pediatr 4:26.